Apple Home Healthcare

applehomehealthcare.com

Apple Home Healthcare is a recognized leader in providing individualized personal skilled home care for seniors at home, in retirement communities, assisted living communities and nursing homes.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

VINCERX PHARMA ANNOUNCES FDA CLEARANCE OF IND FOR VIP943

Globenewswire | August 23, 2023

news image

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported that it has received clearance for its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for VIP943. Vincerx expects to enroll the first patient in the study early in the fourth quarter of 2023. "The IND clearance by the FDA is...

Read More

Business Insights

DICERNA ANNOUNCES EXPIRATION OF HART-SCOTT-RODINO ACT WAITING PERIOD FOR NOVO NORDISK TENDER OFFER TO ACQUIRE DICERNA

Dicerna Pharmaceuticals, Inc. | December 27, 2021

news image

Dicerna Pharmaceuticals, Inc. announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, on December 24, 2021. As previously announced on November 18, 2021, Novo Nordisk commenced a cash tender offer to purchase all outstanding shares of Dicerna common stock for $38.25 per share in cash, without interest and subject to any wit...

Read More

Business Insights, PHARMACY MARKET

PCI PHARMA SERVICES EXPANDS BIOLOGICS LEADERSHIP WITH NEW CENTER OF EXCELLENCE FACILITY IN THE MIDWEST

PCI Pharma Services | March 20, 2023

news image

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), announced plans for a new 200,000-square-foot facility in Rockford, Illinois to enhance the organization’s capacity in injectable drug-device combination product assembly of both biologics and small molecules. Building on PCI’s leadership in this space with its Philadelphia Biotech Center of Excellence, the new facility is the second expansion building off the success i...

Read More

VIEWS AND ANALYSIS, PHARMA TECH

ANAQUA AND PATSNAP TEAM UP TO DELIVER AN END-TO-END PHARMA IP MANAGEMENT SOLUTION

Anaqua and PatSnap | December 08, 2022

news image

Anaqua, the leading provider of innovation and intellectual property management technology announced it is partnering with innovation intelligence platform PatSnap. The collaboration will deliver an enhanced IP management solution to provide Anaqua’s pharmaceutical industry clients with a more detailed and informed view of the market and competitive landscape for key use cases. The combined Anaqua AQX® Pharma and PatSnap Synapse solutions will help AQX Pharma clients further enhance co...

Read More
news image

Pharmacy Market

VINCERX PHARMA ANNOUNCES FDA CLEARANCE OF IND FOR VIP943

Globenewswire | August 23, 2023

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported that it has received clearance for its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for VIP943. Vincerx expects to enroll the first patient in the study early in the fourth quarter of 2023. "The IND clearance by the FDA is...

Read More
news image

Business Insights

DICERNA ANNOUNCES EXPIRATION OF HART-SCOTT-RODINO ACT WAITING PERIOD FOR NOVO NORDISK TENDER OFFER TO ACQUIRE DICERNA

Dicerna Pharmaceuticals, Inc. | December 27, 2021

Dicerna Pharmaceuticals, Inc. announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, on December 24, 2021. As previously announced on November 18, 2021, Novo Nordisk commenced a cash tender offer to purchase all outstanding shares of Dicerna common stock for $38.25 per share in cash, without interest and subject to any wit...

Read More
news image

Business Insights, PHARMACY MARKET

PCI PHARMA SERVICES EXPANDS BIOLOGICS LEADERSHIP WITH NEW CENTER OF EXCELLENCE FACILITY IN THE MIDWEST

PCI Pharma Services | March 20, 2023

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), announced plans for a new 200,000-square-foot facility in Rockford, Illinois to enhance the organization’s capacity in injectable drug-device combination product assembly of both biologics and small molecules. Building on PCI’s leadership in this space with its Philadelphia Biotech Center of Excellence, the new facility is the second expansion building off the success i...

Read More
news image

VIEWS AND ANALYSIS, PHARMA TECH

ANAQUA AND PATSNAP TEAM UP TO DELIVER AN END-TO-END PHARMA IP MANAGEMENT SOLUTION

Anaqua and PatSnap | December 08, 2022

Anaqua, the leading provider of innovation and intellectual property management technology announced it is partnering with innovation intelligence platform PatSnap. The collaboration will deliver an enhanced IP management solution to provide Anaqua’s pharmaceutical industry clients with a more detailed and informed view of the market and competitive landscape for key use cases. The combined Anaqua AQX® Pharma and PatSnap Synapse solutions will help AQX Pharma clients further enhance co...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us